We are live on ! Find out more
FMED icon

Fidelity Disruptive Medicine ETF

7 hedge funds and large institutions have $34.6M invested in Fidelity Disruptive Medicine ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

17% more funds holding

Funds holding: 67 (+1)

11% more capital invested

Capital invested by funds: $31.1M → $34.6M (+$3.53M)

3.5% more ownership

Funds ownership: 62.13%65.63% (+3.5%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$1.07M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17.6M +$2.22M +95,250 +15%
Wealth Enhancement Advisory Services
2
Wealth Enhancement Advisory Services
Minnesota
$16.5M +$1.79M +76,538 +13%
Jane Street
3
Jane Street
New York
$494K -$1.07M -45,755 -69%
PSFG
4
Park Square Financial Group
Georgia
$14.1K
UBS Group
5
UBS Group
Switzerland
$14K +$13.6K +584 New
CPBTD
6
Central Pacific Bank - Trust Division
Hawaii
$2.32K
GEA
7
Glen Eagle Advisors
New Jersey
$2.16K

FMED Hedge Fund Activity: Q2 2025 in Review

7 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q2 2025, worth a combined $34.6M — up 11% from $31.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new FMED positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $2.22M. The largest seller was Jane Street, cutting an estimated $1.07M.

  • 7 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q2 2025, up from 6 in Q1 2025.
  • Funds reported $34.6M of Fidelity Disruptive Medicine ETF stock for Q2 2025, up 11% quarter-over-quarter.
  • 1 fund opened new Fidelity Disruptive Medicine ETF positions in Q2 2025 and 0 closed out, a net change of +1 holder.
  • The largest Fidelity Disruptive Medicine ETF buyer in Q2 2025 was Fidelity Investments, an estimated $2.22M added.
  • The largest Fidelity Disruptive Medicine ETF seller in Q2 2025 was Jane Street, an estimated $1.07M sold.

Based on aggregated 13F filings for Q2 2025.